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Introduction
We have all seen it in the news. Antibiotic resistance is increasing 1. In fact, the World Health Organization
has said that antibiotic resistance is becoming a very serious threat to global health 2. With bacteria and fungi being
able to readily adapt and fend off the drugs that were designed to kill them, new medicines will need to be made in
order to protect us. A common household antibiotic drug that is used is penicillin. Bacteria has a guardian – an
enzyme that works hard to build up the bacteria’s outer defense. Penicillin inhibits this enzyme with a weapon called
the β-Lactam ring structure 3 (Figure One). This weapon disables the enzyme and weakens the protective
peptidoglycan outer layer of the bacteria. However, over time, bacteria have mutated to become heavily resistant to
the β-Lactam ring 4. New antibiotics with varied structures are needed to treat this new form of resistant bacteria.
Research Question
Our research project will focus on the synthesis and characterization of a different breed of antibiotics –
anthranilic acid derivatives (Figure Two). Discovered at GVSU, we have a lead compound that has antibiotic
activity while not having a β-Lactam ring. This chemical is called 2-amino-5-bromobenzoic acid and has a common
name called anthranilic acid 5. With this research project, we will be attaching different atoms and structures onto
this lead compound via organic synthesis. These novel structures will then be biologically tested to see if we can
discover something with more activity than the lead compound.

Figure One: Penicillin

Figure Two: 2-amino-5-bromobenzoic acid
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Methods

The specific goals of this project are to (1) Chemically synthesize anthranilic acid derivatives, (2) Purify
and characterize these new derivatives, and (3) have them tested for antibiotic activity. During this project, the
synthesized chemicals will be characterized using modern spectroscopic methods including: 1H-NMR, 12C-NMR,
thin layer chromatography, melting point, and infrared spectroscopy . Then, these chemicals will be tested for
antibiotic properties against several strains of bacteria. Staphylococcus aureus (Figure Three) – which causes staph
infections – will be one of the bacteria that the compounds will be tested against 6.

Figure Three: Staphylococcus aureus
One of the products synthesized was 4,5-dibromo-2-(undec-10-enamido)benzoic acid. The overall
synthesis was a combination of 2-amino-4,5-dibromobenzoic acid and 10-undecenoylchloride in a solution of
K2CO3 and 1,2-dimethoxyethane. Nucleophilic acyl substitution drives this reaction. The amine nitrogen of 2amino-4,5-dibromobenzoic acid attacks the carbonyl of the alkenoyl chloride in the solution of K2CO3 and 1,2dimethoxyethane. The chloride is the leaving group. A sample reaction can be seen below (Figure Four).
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Figure Four: Nucleophilic acyl substitution reaction
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Results

These new derivatives of anthranilic acid will help establish antibiotic structure activity relationships. We
will modify the alkyl chain of the lead structure as well as different atoms attached to the base of the molecule to
find a relationship between the structures and their antibiotic activity.
This research project includes data collection via 1H-NMR, 12C-NMR, thin layer chromatography, melting
point, and infrared spectroscopy to determine purity for biological testing. An example of how this will be tested for
biological activity, can be seen in area 13 (Figure Five) – treated with 5-chloro-2-(undec-10-enamido) benzoic acid
– where the inability of Staphylococcus aureus to grow into that area shows that this chemical was active against the
bacteria 7. An example of how this will be characterized is shown below (Figure Six). More data results are pending
return to the lab.

5-chloro-2-(undec-10-enamido) benzoic acid

Figure Five: 5-chloro-2-(undec-10-enamido) benzoic acid against a Staphylococcus aureus colony 7

3,5-dibromo-2(undec-10enamido) benzoic
acid
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Figure Six: Characterized for 3,5-dibromo-2-(undec-10-enamido)benzoic acid
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Discussion of Results
The synthesis of 4,5-dibromo-2-(undec-10-enamido) benzoic acid had a yield of 38.9%. The overall
synthesis was a combination of 2-amino-4,5-dibromobenzoic acid and 10-undecenoylchloride in a solution of K2CO3
and 1,2-dimethoxyethane. The melting points upon recrystallization were 186-207oC and 183-202oC. These melting
points suggest impurities. A TLC plate was ran using 75% ethyl acetate, 25% hexanes, and 2% acetic acid as the
mobile phase. The TLC ran for about 10 minutes and notably, the reactants had a color change to yellow. The Rf
value in the substrate lane was 0.94. The Rf values in the product lane were 0.94 and 0.80. The Rf values in the co
lane were 0.94 and 0.80. This specific chemical is not considered pure until an NMR is taken and analyzed. Data
from other chemicals are currently unavailable pending return to the lab.
Future Work
Overall, the chemistry synthesis worked well, but there is still much analysis and purification that needs to
happen. Research in the future will include an experiment to test different reagents in an attempt to increase yield.
Additional research will include brominating of the alkenes to see how this change will impact the structure activity
relationship with bacteria. After purification and further analysis of the data, these chemicals will be able to undergo
microbial testing with different kinds of bacteria and find the relationship between the structure and the activity with
the bacteria.

